Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial.
Bianca T A de Greef, Janneke G J Hoeijmakers, Margot Geerts...
https://pubmed.ncbi.nlm.nih.gov/30649227/Actively Recruiting
Led by Maastricht University Medical Center · Updated on 2026-09-21
124
Participants Needed
1
Research Sites
N/A
Total Duration
Small fiber neuropathy SFN is a condition where the smallest nerve fibers are damaged, causing severe pain and disturbances in the bodys automatic functions, which greatly reduce quality of life. Current pain medications often have limited effects and can cause unwanted side effects. Although SFN involves peripheral nerves, brain activity differences suggest the brain may be a treatment target. Researchers are exploring repetitive Transcranial Magnetic Stimulation rTMS, a non-invasive brain stimulation technique, to assess its potential for pain relief in SFN. Participants will receive either active or sham rTMS over a six-week induction phase with 14 sessions total. Initially, four sessions per week occur for two weeks, followed by two sessions per week for two weeks, and one session per week for the final two weeks. Responders to active treatment with at least a 1-point improvement in pain may enter a six-week maintenance phase with weekly sessions, randomized to active or sham rTMS. Throughout the study, participants will be monitored for pain relief, pain qualities, SFN-related symptoms, daily functioning, quality of life, and safety. Evaluations include pain intensity scales, symptom inventories, disability outcome scales, and quality-of-life questionnaires, collected up to six months. Adverse events will be tracked up to 12 weeks and six months, with the primary outcome focusing on pain improvement after six weeks of treatment.
CONDITIONS
Magnetic Brain Stimulation in Small Fiber Neuropathy
E
Eva C.M. Gruintjes, MD
J
Janneke G.J. Hoeijmakers, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Maastricht University Medical Center
Lead Sponsor
Princess Beatrix Muscle Foundation
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 6 weeks
Participants receive either active or sham repetitive Transcranial Magnetic Stimulation (rTMS) over six weeks with 14 sessions. The schedule includes four sessions per week for two weeks, then two sessions per week for two weeks, followed by one session per week for two weeks.
14 sessions over 6 weeks
Duration - 6 weeks
Participants who respond to active treatment are randomized again to receive either active or sham rTMS once weekly for six weeks, totaling six sessions.
6 weekly sessions
Duration - Up to 6 months
Participants are monitored for pain levels, symptoms, daily functioning, quality of life, and safety for up to six months after treatment begins.
Regular assessments throughout
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Bianca T A de Greef, Janneke G J Hoeijmakers, Margot Geerts...
https://pubmed.ncbi.nlm.nih.gov/30649227/Dennis Kool, Janneke Gj Hoeijmakers, Stephen G Waxman...
https://pubmed.ncbi.nlm.nih.gov/39580213/Nadine Attal, Frédérique Poindessous-Jazat, Edwige De Chauvigny...
https://pubmed.ncbi.nlm.nih.gov/34196698/Nobuhiko Mori, Koichi Hosomi, Asaya Nishi...
https://pubmed.ncbi.nlm.nih.gov/38782994/Martin Tik, André Hoffmann, Ronald Sladky...
https://pubmed.ncbi.nlm.nih.gov/28912081/P M Rossini, D Burke, R Chen...
https://pubmed.ncbi.nlm.nih.gov/25797650/Andrés Molero-Chamizo, Michael A Nitsche, Rafael Tomás Andújar Barroso...
https://pubmed.ncbi.nlm.nih.gov/36979932/Ivo Eijkenboom, Maurice Sopacua, Auke B C Otten...
https://pubmed.ncbi.nlm.nih.gov/30316835/Jessica Robinson-Papp, Mary Catherine George, David Dorfman...
https://pubmed.ncbi.nlm.nih.gov/25688752/Janneke G Hoeijmakers, Catharina G Faber, Giuseppe Lauria...
https://pubmed.ncbi.nlm.nih.gov/22641108/Maastricht University Medical Center
Lead Sponsor
Princess Beatrix Muscle Foundation
Collaborating Sponsor